Page last updated: 2024-09-03

gefitinib and manganese dioxide

gefitinib has been researched along with manganese dioxide in 1 studies

Compound Research Comparison

Studies (gefitinib)	Trials (gefitinib)	Recent Studies (post-2010) (gefitinib)	Studies (manganese dioxide)	Trials (manganese dioxide)	Recent Studies (post-2010) (manganese dioxide)
5,231	566	2,919	675	1	469

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, E; Hu, H; Xu, L; Zhang, J	1

Other Studies

1 other study(ies) available for gefitinib and manganese dioxide

Article	Year
The combination of MnO Drug delivery, 2022, Volume: 29, Issue:1 Topics: Animals; Antineoplastic Agents; Apoptosis; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Combinations; Drug Liberation; Gefitinib; Humans; Hydrogen-Ion Concentration; Lung Neoplasms; Manganese Compounds; Mice; Mice, Inbred BALB C; Nanotubes; Oxides; Particle Size; Surface Properties; Xenograft Model Antitumor Assays	2022

Article

Year

The combination of MnO

Drug delivery, 2022, Volume: 29, Issue:1

Topics: Animals; Antineoplastic Agents; Apoptosis; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Combinations; Drug Liberation; Gefitinib; Humans; Hydrogen-Ion Concentration; Lung Neoplasms; Manganese Compounds; Mice; Mice, Inbred BALB C; Nanotubes; Oxides; Particle Size; Surface Properties; Xenograft Model Antitumor Assays

2022